These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11347755)

  • 1. Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes.
    Bojestig M; Karlberg BE; Lindström T; Nystrom FH
    Diabetes Care; 2001 May; 24(5):919-24. PubMed ID: 11347755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial.
    O'Hare P; Bilbous R; Mitchell T; O' Callaghan CJ; Viberti GC;
    Diabetes Care; 2000 Dec; 23(12):1823-9. PubMed ID: 11128360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.
    Weekers L; Bouhanick B; Hadjadj S; Gallois Y; Roussel R; Pean F; Ankotche A; Chatellier G; Alhenc-Gelas F; Lefebvre PJ; Marre M
    Diabetes; 2005 Oct; 54(10):2961-7. PubMed ID: 16186399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function.
    Poulsen PL; Ebbehøj E; Nosadini R; Fioretto P; Deferrari G; Crepaldi G; Mogensen CE
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):123-8. PubMed ID: 11353877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria.
    Fogari R; Mugellini A; Zoppi A; Preti P; Maffioli P; Perrone T; Derosa G
    Expert Opin Pharmacother; 2013 Mar; 14(4):371-84. PubMed ID: 23414196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
    Toto RD; Adams-Huet B; Fenves AZ; Mitchell HC; Mulcahy W; Smith RD
    Am J Kidney Dis; 1996 Dec; 28(6):832-40. PubMed ID: 8957034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes.
    Marre M; Hallab M; Billiard A; Le Jeune JJ; Bled F; Girault A; Fressinaud P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S165-8. PubMed ID: 1725033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study.
    Poulsen PL; Ebbehøj E; Mogensen CE
    J Intern Med; 2001 May; 249(5):433-40. PubMed ID: 11350567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over two years.
    Pedersen EB; Bech JN; Nielsen CB; Kornerup HJ; Hansen HE; Spencer ES; Sølling J; Jensen KT
    Scand J Clin Lab Invest; 1997 Dec; 57(8):673-81. PubMed ID: 9458489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
    Marre M; Lievre M; Chatellier G; Mann JF; Passa P; Ménard J;
    BMJ; 2004 Feb; 328(7438):495. PubMed ID: 14960504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M; Brosh D; Levi Z; Bar-Dayan Y; Ravid D; Rachmani R
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
    de Azevedo MJ; Ramos OL; Gross JL
    Horm Metab Res; 1997 Oct; 29(10):516-9. PubMed ID: 9405980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
    Azizi M; Bissery A; Peyrard S; Guyene TT; Ozoux ML; Floch A; Ménard J
    Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
    Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impediment of the progressions of microalbuminuria and hyperlipidemia in normotensive type 2 diabetes by low-dose ramipril.
    Vongterapak S; Dahlan W; Nakasatien S; Anuntakulnatee T; Suppanich M; Kittipoom W; Surasingchaidet C; Tamwiwat C; Tepkasetkul M; Bunnag P; Ongphiphadhanakul B; Rajatanavin R; Himathongkam T
    J Med Assoc Thai; 1998 Sep; 81(9):671-81. PubMed ID: 9737124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.
    Komers R; Simkova R; Kazdova L; Ruzickova J; Pelikanova T
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):33-8. PubMed ID: 15136972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
    Azizi M; Ménard J; Peyrard S; Lièvre M; Marre M; Chatellier G
    Diabetes Care; 2006 Jun; 29(6):1331-6. PubMed ID: 16732017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension.
    Soergel M; Verho M; Wühl E; Gellermann J; Teichert L; Schärer K
    Pediatr Nephrol; 2000 Nov; 15(1-2):113-8. PubMed ID: 11095026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.